Videx Powder For Oral Solution 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Videx: Powder for oral solution (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

DIDANOSINE, ddI (dye DAN oh seen) is an antiretroviral medicine. It is used with other medicines to treat HIV. This medicine is not a cure for HIV. It will not stop the spread of HIV to others.

In-Depth Information
Select a Medication

Videx Pediatric 4g Powder for Solution

NDC: 000876633
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Human Immunodeficiency Virus (HIV) Infection

Storage Information
Discard unused reconstituted product after 30 days
Store unreconstituted product at 59 to 86 degrees F
Store reconstituted product in refrigerator (between 36 to 46 degrees F) for up to 30 days
Videx Pediatric 4g Powder for Solution

Reported Side Effects for Videx Pediatric 4g Powder for Solution

Dry Mouth Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Electrolyte Imbalance Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Disease Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Breakdown Of Muscle Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Weakness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Chills Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Vomiting Of Blood Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Liver Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Kidney Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Retinal Pigment Changes Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Removal Of Spleen Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Fatty Change Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Hair Loss Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Extra Abdominal Fluid Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Diabetes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Dry Eyes Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Low Blood Sugar Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Muscle Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Optic Nerve Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Infected Salivary Gland Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Pancreas Incidence:
1.0-13.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
1.0-9.0%*
Severity: MODERATE
Onset: DELAYED
High Uric Acid Level Incidence:
2.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
7.0-9.0%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
7.0-9.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
7.0-13.0%*
Severity: MILD
Onset: EARLY
High Bilirubin Level Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
12.0-30.0%*
Severity: MILD
Onset: EARLY
High Amylase Levels Incidence:
15.0-17.0%*
Severity: MODERATE
Onset: DELAYED
Nerve Pain Incidence:
17.0-20.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
19.0-28.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
21.0-46.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
24.0-53.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Videx Pediatric 4g Powder for Solution

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Food and Videx Pediatric 4g Powder for Solution(Didanosine)
Food and Didanosine(Didanosine)
Didanosine, ddI, should be given 30 minutes before or 2 hours after meals.
Moderate Lifestyle Interaction
Marijuana and Videx Pediatric 4g Powder for Solution(Didanosine)
Marijuana and Nucleoside reverse transcriptase inhibitors(Didanosine)
Although an interaction is possible, these drugs may be used together. In therory, side effects from Marijuana, Medical may get worse if you take Anti-retroviral nucleoside reverse transcriptase inhibitors (NRTIs). However, the importance of this interaction is not known. Notify your health care provider if you notice increased fatigue, nausea, vomiting, or any other unusual effects.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Videx

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5